← Tra cứu cổ phiếu
Viewing Quý 1/2026Latest period →

iShareInvest Research

HNX · Quý 1/2026

VHE

Dược liệu và Thực phẩm Việt Nam

Analysis of business results & financial statements · Quý 1/2026

▲▲ Improving positively

Trailing net profit reached 21.5bn, rose 18.2bn compared with the same period last year. Key positives came from higher gross profit. Offsetting pressure came mainly from higher finance costs and higher tax. Detailed impact is shown below:

See what is changing ↓
P/E
4.15x
P/B
0.23x
EPS
651
BVPS
11,529
ROE
5.8%
ROA
3.7%
Market price
2,700
16 Oct 2026

What Is Changing

On a TTM 2026Q1 basis, VHE has not accelerated revenue sharply, but profitability is improving visibly — profit is at an all-time high. However, operating cash flow is significantly negative relative to profit — this needs monitoring in coming periods.

Profit bridge

Vs last year · TTM

  1. Gross profit
  2. Finance costs
  3. Tax
Unit: VND bn. Green bars support profit; red bars reduce profit.

A single data point, or a trajectory?

Latest eight quarters · Quý 1/2026

MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24
Revenue157.6116.048.9212.8157.062.3144.2163.7
LNST5.22.52.611.41.20.50.81.0
Net margin3.27%2.18%5.28%5.35%0.74%0.77%0.52%0.64%

Revenue

158bn

Net income

5bn

Net margin

3.27%

A closer look at what is happening inside the business

A company's statements are read with the questions that fit its type of business.

01

Is the profit sustainable?

Accounting profit is positive but operating cash flow has not caught up — needs more time to confirm.

What is driving the margin?

▲▲

Net margin expanded to 4.04%, rising 3.4pp. The main driver is Gross margin rose 6.0pp and SG&A / Revenue fell 0.1pp, moving in line with the stronger net margin (with lingering pressure from Net financial result / Revenue fell 1.6pp and Other profit / Revenue fell 0.2pp).

The improvement comes from core operations — this is a high-quality margin expansion.

Net Margin
4.04%
+3.4pp
Gross Margin
9.42%
+6.0pp
SG&A / Revenue
1.24%
−0.1pp

TTM YoY · 2025Q1 -> 2026Q1

02

Is capital being used efficiently?

Return on capital rose, but cash cycle lengthened by 52.0 days — working capital needs watching.

Is capital being deployed efficiently?

▲▲

ROIC expanded to 3.91%, rising 3.4pp. That translates to 3.91 in after-tax operating profit for every 100 units of operating capital. The main driver is NOPAT margin rose 3.6pp, with capital turnover fell 0.19x; while invested capital expanded strongly by 98bn.

NOPAT margin is the main cushion preventing ROIC from slipping as invested capital keeps expanding — the quality of this improvement depends on whether margin holds once the new capital is fully deployed.

ROIC remains low

ROIC is currently 3.91% — below the typical cost-of-capital threshold; worth tracking whether upcoming periods can rise above this level.

Balance Sheet

▼

ROIC is improving — the asset structure below shows how capital is being allocated. Capital structure is balanced — liabilities at 0.65x equity, net debt at 0.58x equity.

Inventory ended the period at 320.3bn, roughly 51.6% of total assets.

Over the last 12 months, working capital absorbed 119.2bn of cash, mainly because of higher receivables and higher inventories.

Working Capital Efficiency

▼▼

Cash conversion cycle lengthened by 52.0 days versus the same period last year. The main moves came from DIO rose 48.0 days, DSO rose 5.3 days, and DPO rose 1.3 days.

Working capital cycle lengthened mainly due to slower inventory turnover — more capital is being tied up in inventory.

Cash conversion cycle remains stretched

CCC stands at 219.1 days, suggesting that working capital remains tied up for a relatively long operating cycle.

Receivables collection is slowing

DSO increased by +5.3 days, pointing to slower receivables turnover.

DuPont

What drives ROE?

Net margin 4.0% +3.4pp
Asset turnover 0.92x -0.16x
Financial leverage 1.57x +0.16x
ROE 5.8% +4.8pp

ROE rose from 1.0% to 5.8% — mainly driven by net margin, despite asset turnover moving in the opposite direction.

03

Is financial risk significant?

Check leverage, liquidity, and cash-flow conversion.

Leverage & Liquidity

▼▼

Leverage warrants monitoring, with net debt / equity at 0.58x and interest coverage only at 1.65x.

At present, short-term debt accounts for 99.8% of total debt, cash equals 4.9% of debt, and total debt stands at 232.5bn.

Interest coverage is thin

Interest coverage is 1.65x, leaving limited room to absorb financing costs.

Short-term refinancing pressure is meaningful

Short-term debt accounts for 99.8% of total debt, raising near-term refinancing needs.

Net Debt / Equity
0.58x
+0.16x
Interest Coverage
1.65x
+1.28x
Cash / Debt
4.9%
+0.9pp
Short-term Debt / Total Debt
99.8%
+0.2pp

TTM YoY · 2025Q1 -> 2026Q1

Cash Flow

●

Operating cash flow reached -109.6bn in 2025, against investing cash flow of 16.5bn.

Post-investment cash flow was negative +93.0bn. Financing cash flow was positive +97.5bn.

CFO / net income was −3,98 lần.

Track how much investment can be funded internally from operating cash flow.

Cash capex or FCF data is incomplete, so the cash-conversion view is only partial.

Research synthesis

What this reporting period is showing

The business is under real pressure, but the current picture has not turned broadly adverse. A notable area has clearly weakened, making the near-term outlook hard to call bright; even so, other parts of the business are still holding up, with capital efficiency remains weak remaining the main constraint, with ROIC at 3.9%. The next watchpoint is cash generation still needs confirmation. The main offsetting support comes from operating efficiency, with net margin improving 3.4 pp.

  • Improvement: operating efficiency is getting better, with trailing-12M net margin at 4.04% after expanding 3.4pp versus the same period last year.
  • Watchpoint: Cash generation still needs confirmation.
  • Key risk: Capital efficiency remains weak.

Questions for the next period

  1. Durability of revenue growth after the current +1,6% YoY pace.

  2. Ability to hold margins around the current 4.04% level.

  3. Cash-flow quality, with operating cash flow currently at -109.6bn in 2025.

From one stock to the whole portfolio

Where does this stock stand
among the rest of your investments?

Each stock is only one part of the wider picture. Looking at investments side by side makes their contribution, risks and opportunities across the portfolio clearer.

How much does this stock
contribute to the portfolio?

Its weight and influence across the assets held for investment.

Is the portfolio
well balanced?

How holdings, sectors and asset groups are distributed in relation to overall risk.

What other opportunities
or risks may be present?

What becomes visible only when investments are viewed together rather than one ticker at a time.

View my portfolio